Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer.

Pai SG, Carneiro BA, Chae YK, Costa RL, Kalyan A, Shah HA, Helenowski I, Rademaker AW, Mahalingam D, Giles FJ.

J Gastrointest Oncol. 2017 Oct;8(5):858-866. doi: 10.21037/jgo.2017.06.20.

2.

Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.

Rajeshkumar NV, Yabuuchi S, Pai SG, De Oliveira E, Kamphorst JJ, Rabinowitz JD, Tejero H, Al-Shahrour F, Hidalgo M, Maitra A, Dang CV.

Clin Cancer Res. 2017 Sep 15;23(18):5639-5647. doi: 10.1158/1078-0432.CCR-17-1115. Epub 2017 Jun 13.

3.

Wnt/beta-catenin pathway: modulating anticancer immune response.

Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ.

J Hematol Oncol. 2017 May 5;10(1):101. doi: 10.1186/s13045-017-0471-6. Review.

4.

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials.

Costa R, Carneiro BA, Agulnik M, Rademaker AW, Pai SG, Villaflor VM, Cristofanilli M, Sosman JA, Giles FJ.

Oncotarget. 2017 Jan 31;8(5):8910-8920. doi: 10.18632/oncotarget.13315. Review.

5.

Genomic characterization of high-risk non-muscle invasive bladder cancer.

Meeks JJ, Carneiro BA, Pai SG, Oberlin DT, Rademaker A, Fedorchak K, Balasubramanian S, Elvin J, Beaubier N, Giles FJ.

Oncotarget. 2016 Nov 15;7(46):75176-75184. doi: 10.18632/oncotarget.12661.

6.

Long-acting interferon for myeloproliferative neoplasms - an update.

Pai SG, Kaplan JB, Giles FJ.

Expert Rev Hematol. 2016 Oct;9(10):915-7. doi: 10.1080/17474086.2016.1231571. Epub 2016 Sep 13. No abstract available.

PMID:
27584865
7.

Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.

Rajeshkumar NV, Yabuuchi S, Pai SG, Tong Z, Hou S, Bateman S, Pierce DW, Heise C, Von Hoff DD, Maitra A, Hidalgo M.

Br J Cancer. 2016 Aug 9;115(4):442-53. doi: 10.1038/bjc.2016.215. Epub 2016 Jul 21.

8.

The challenge of developmental therapeutics for adrenocortical carcinoma.

Costa R, Carneiro BA, Tavora F, Pai SG, Kaplan JB, Chae YK, Chandra S, Kopp PA, Giles FJ.

Oncotarget. 2016 Jul 19;7(29):46734-46749. doi: 10.18632/oncotarget.8774. Review.

9.

The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.

Chae YK, Gagliato Dde M, Pai SG, Carneiro B, Mohindra N, Giles FJ, Ramakrishnan-Geethakumari P, Sohn J, Liu S, Chen H, Ueno N, Hortobagyi G, Gonzalez-Angulo AM.

PLoS One. 2016 Apr 7;11(4):e0152585. doi: 10.1371/journal.pone.0152585. eCollection 2016.

10.

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Costa R, Carneiro BA, Chandra S, Pai SG, Chae YK, Kaplan JB, Garrett HB, Agulnik M, Kopp PA, Giles FJ.

Drug Des Devel Ther. 2016 Feb 29;10:873-84. doi: 10.2147/DDDT.S93459. eCollection 2016. Review.

11.

Novel therapeutic agents in the treatment of metastatic colorectal cancer.

Pai SG, Fuloria J.

World J Gastrointest Oncol. 2016 Jan 15;8(1):99-104. doi: 10.4251/wjgo.v8.i1.99. Review.

12.

Angiotensin receptor blockers: are they related to lung cancer?

Rao GA, Mann JR, Shoaibi A, Pai SG, Bottai M, Sutton SS, Haddock KS, Bennett CL, Hebert JR.

J Hypertens. 2013 Aug;31(8):1669-75. doi: 10.1097/HJH.0b013e3283621ea3.

13.

Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.

Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, Rajeshkumar NV.

Cancer Lett. 2013 Jul 10;335(1):41-51. doi: 10.1016/j.canlet.2013.01.054. Epub 2013 Feb 10.

14.

Cataract surgery in camp patients: a study on visual outcomes.

Pai SG, Kamath SJ, Kedia V, Shruthi K, Pai A.

Nepal J Ophthalmol. 2011 Jul-Dec;3(2):159-64. doi: http://dx.doi.org/10.3126/nepjoph.v3i2.5270.

PMID:
21876591
15.

Ethics and medico legal aspects of "not for resuscitation".

Salins NS, Pai SG, Vidyasagar M, Sobhana M.

Indian J Palliat Care. 2010 May;16(2):66-9. doi: 10.4103/0973-1075.68404.

16.

Symptomatic hypocalcemia in primary hyperaldosteronism: a case report.

Pai SG, Shivashankara KN, Pandit V, Sheshadri S.

J Korean Med Sci. 2009 Dec;24(6):1220-3. doi: 10.3346/jkms.2009.24.6.1220. Epub 2009 Nov 9.

17.

Microbial degradation of mefenoxam in rhizosphere of Zinnia angustifolia.

Pai SG, Riley MB, Camper ND.

Chemosphere. 2001 Aug;44(4):577-82.

PMID:
11482644
18.
19.

Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, and pathologic findings in four affected fetuses.

Powers JM, Moser HW, Moser AB, Upshur JK, Bradford BF, Pai SG, Kohn PH, Frias J, Tiffany C.

Hum Pathol. 1985 Jun;16(6):610-20.

PMID:
3997138

Supplemental Content

Support Center